跳至主要内容
临床试验/TCTR20240816008
TCTR20240816008尚未招募2 期

Efficacy of Dexamethasone Versus N-acetylcysteine in preventing post-embolization syndrome after trans arterial chemoembolization in hepatocellular carcinoma: A randomized controlled trial

FACULTY OF MEDICINE VAJIRA HOSPITAL foundation for research0 个研究点目标入组 100 人开始时间: 2024年8月16日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • age 18-70 yrs old was diagnosis of Hepatocellular carcinoma who underwent conventional TACE

排除标准

  • decompensated cirrhosis
  • congestive heart failure with or without respiration failure
  • severe comorbidity (uncontrolled DM, HbA1C >8.5, untreated HIV infection)
  • drug allergen to N-acetylcysteine, dexamethasone
  • previous use of NSIADs /steroids / N-acetylcysteine
  • contraindication of TACE
  • ongoing sepsis

研究者

发起方
FACULTY OF MEDICINE VAJIRA HOSPITAL foundation for research

相似试验